Biomashinostroene AD was established in 1986 as a company specialized in bio technologies. The company specializes in the design and production of technological equipment (vessels, apparatuses, heat converters, installations, pressurized equipment) for the food processing and pharmaceutical industries. The main principle in the company’s activity is offering professional, innovative and tailor-made technical solutions to satisfy customers’ specific requirements, in accordance to the given technical specifications. Biomashinostroene AD’s main competitors are producers from Western Europe – Germany, Italy, and Poland. Biomashinostroene AD’s advantages are the good quality and the lower product price, thanks to lower labour costs. Competitors’ products have high quality, but relatively higher prices. Biomashinostroene AD’s price advantage is often minimal, due to the fact that the competition compensates with better organization and higher production efficiency. The main limitation preventing the development of Biomashinostroene AD is the insufficient production capacity to meet the increasing order volume. Another challenge for the company is the rising complexity of customers’ technological assignments, which necessitates higher precision demands and flexibility in the parts design. To meet the identified needs, the company plans to invest in modern and precise equipment for the production’s preparation stage. The expected results from the planned investments are accuracy – higher quality, speed – more orders within tighter deadlines, and economy – reduction of scrap, full product utilization. Regarding the product range, Biomashinostroene AD will be able to offer completely new models, easy and quick measuring and modification of details, as well as complex manipulations within short time frames.
Overview
Status | Closed (completion date) |
---|---|
Start date | 23 Dec, 2015 |
End date | 18 Aug, 2017 |
Contract date | 23 Dec, 2015 |
Programme
Beneficiary
Financial information
Total cost | 1,639,134.00 |
---|---|
Grant | 983,480.40 |
Self finance | 655,653.60 |
Total paid | 943,590.61 |
EU participation percent | 85.0% |
Location